63 studies found for:    "antibiotic resistance" | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Diagnostic Tools in Patients With a Suspected Urinary Tract Infection in Primary Care
Condition: Urinary Tract Infections
Intervention: Other: Diagnostic approaches
22 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
23 Recruiting Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Condition: Infection
Interventions: Drug: Ciprofloxacin;   Drug: trimethoprim-sulfamethoxazole;   Drug: cefuroxime;   Drug: ceftriaxone;   Drug: gentamicin;   Drug: amikacin;   Drug: aztreonam;   Drug: imipenem
24 Unknown  Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
25 Unknown  A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
Condition: Infection
Interventions: Dietary Supplement: Lactobacillus rhamnosus;   Dietary Supplement: Sugar pill (placebo)
26 Recruiting Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Conditions: Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions: Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
27 Recruiting Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Condition: Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Intervention: Drug: Cefoxitin
28 Unknown  Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: 10RAC+acetylcystein;   Drug: 10RAC+metronidazole
29 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
30 Not yet recruiting Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
Conditions: Pneumonia;   Diarrhea;   Malaria;   Co-infection;   Death;   Malnutrition
Intervention: Drug: Azithromycin
31 Recruiting Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
Conditions: Urinary Tract Infection;   Recurrent Urinary Tract Infection
Intervention: Drug: Antibiotic Prophylaxis
32 Not yet recruiting Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
Condition: Urinary Tract Infection
Interventions: Other: Antibiotic;   Drug: Probiotic
33 Recruiting Microbiota and Related Metabolome in Omnivore, Vegetarian or Vegan Diets
Condition: Diet and Human Microbiota
Intervention: Other: Omnivore, vegetarian and vegan subjects.
34 Recruiting First Study of Oral Cysteamine in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Cysteamine
35 Recruiting Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Intervention: Drug: povidone-iodine 4%
36 Recruiting Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
Conditions: Infection;   Skin and Subcutaneous Tissue Bacterial Infections;   Healthcare-associated Infection;   Infection Due to Resistant Bacteria
Intervention:
37 Unknown  Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
Condition: Nosocomial Pneumonia
Interventions: Drug: C Group;   Drug: E Group
38 Recruiting Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Sultamicillin;   Drug: Placebo
39 Recruiting Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission
Condition: Burn
Intervention: Other: Systematic Therapeutic Drug Monitoring for the intervention group
40 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years